The nucleocapsid protein specifically anneals tRNA(Lys-3) onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro

被引:15
作者
Chan, B [1 ]
MusierForsyth, K [1 ]
机构
[1] UNIV MINNESOTA,DEPT CHEM,MINNEAPOLIS,MN 55455
关键词
D O I
10.1073/pnas.94.25.13530
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV type 1 (HIV-1) specifically uses host cell tRNA(Lys-3) as a primer for reverse transcription. The 3' 18 nucleotides of this tRNA are complementary to a region on the HIV RNA genome known as the primer binding site (PBS). HIV-1 has a strong preference for maintaining a lysine-specific PBS in vivo, and viral genomes with mutated PBS sequences quickly revert to be complementary tu tRNA(Lys-3). To investigate the mechanism fur thf observed PBS reversion events in vitro, we examined the capability of the nucleocapsid protein (NC) to anneal various tRNA primer sequences onto either complementary or noncomplementary PBSs. We show that NC can anneal different full-length tRNAs onto viral RNA transcripts derived from the HIV-1 MAL or HXB2 isolates, provided that the PBS is complementary to the tRNA used. In contrast, NC promotes specific annealing of only tRNA(Lys-3) onto an RNA template (HXB2) whose PIGS sequence has been mutated to be complementary to the 3' IS nt of human tRNA(Pro). Moreover, HIV-1 reverse transcriptase extends this binary complex from the proline-specific PES. The formation of the noncomplementary binary complex does not occur when a chimeric tRNA(Lys/Pro) containing proline-specific D and anticodon domains is used as the primer, Thus, elements outside the acceptor-T Psi C domains of tRNA(Lys-3) play an important role in preferential primer use in vitro. Our results support the hypothesis that mutant PBS reversion is a result of tRNA(Lys-3) annealing onto end extension from a PBS that specifies an alternate host cell tRNA.
引用
收藏
页码:13530 / 13535
页数:6
相关论文
共 45 条
[1]   Restoration of tRNA(3)(Lys)-primed (-)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs - Implications for retroviral replication [J].
Arts, EJ ;
Ghosh, M ;
Jacques, PS ;
Ehresmann, B ;
LeGrice, SFJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :9054-9061
[2]   HIV-1 REVERSE-TRANSCRIPTASE SPECIFICALLY INTERACTS WITH THE ANTICODON DOMAIN OF ITS COGNATE PRIMER TRANSFER-RNA [J].
BARAT, C ;
LULLIEN, V ;
SCHATZ, O ;
KEITH, G ;
NUGEYRE, MT ;
GRUNINGERLEITCH, F ;
BARRESINOUSSI, F ;
LEGRICE, SFJ ;
DARLIX, JL .
EMBO JOURNAL, 1989, 8 (11) :3279-3285
[3]   FUNCTIONAL SITES IN THE 5' REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FORM DEFINED STRUCTURAL DOMAINS [J].
BAUDIN, F ;
MARQUET, R ;
ISEL, C ;
DARLIX, JL ;
EHRESMANN, B ;
EHRESMANN, C .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (02) :382-397
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS USES TRNA(LYS,3) AS PRIMER FOR REVERSE TRANSCRIPTION IN HELA-CD4(+) CELLS [J].
DAS, AT ;
KOKEN, SEC ;
ESSINK, BBO ;
VANWAMEL, JLB ;
BERKHOUT, B .
FEBS LETTERS, 1994, 341 (01) :49-53
[5]   EFFICIENT EXTENSION OF A MISALIGNED TRANSFER-RNA-PRIMER DURING REPLICATION OF THE HIV-1 RETROVIRUS [J].
DAS, AT ;
BERKHOUT, B .
NUCLEIC ACIDS RESEARCH, 1995, 23 (08) :1319-1326
[6]   REDUCED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS THAT USE REVERSE TRANSCRIPTION PRIMERS OTHER THAN THE NATURAL TRNA(3)(LYS) [J].
DAS, AT ;
KLAVER, B ;
BERKHOUT, B .
JOURNAL OF VIROLOGY, 1995, 69 (05) :3090-3097
[7]   VIRAL-RNA ANNEALING ACTIVITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NUCLEOCAPSID PROTEIN REQUIRE ONLY PEPTIDE DOMAINS OUTSIDE THE ZINC FINGERS [J].
DEROCQUIGNY, H ;
GABUS, C ;
VINCENT, A ;
FOURNIEZALUSKI, MC ;
ROQUES, B ;
DARLIX, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6472-6476
[8]   DETAILED MODEL OF REVERSE TRANSCRIPTION AND TESTS OF CRUCIAL ASPECTS [J].
GILBOA, E ;
MITRA, SW ;
GOFF, S ;
BALTIMORE, D .
CELL, 1979, 18 (01) :93-100
[9]   OMPT ENCODES THE ESCHERICHIA-COLI OUTER-MEMBRANE PROTEASE THAT CLEAVES T7-RNA POLYMERASE DURING PURIFICATION [J].
GRODBERG, J ;
DUNN, JJ .
JOURNAL OF BACTERIOLOGY, 1988, 170 (03) :1245-1253
[10]   Synthesis and aminoacyl-tRNA synthetase inhibitory activity of prolyl adenylate analogs [J].
Heacock, D ;
Forsyth, CJ ;
Shiba, K ;
MusierForsyth, K .
BIOORGANIC CHEMISTRY, 1996, 24 (03) :273-289